产品详情
靶点信息
EGFR (L858R) (Cell-free assay) | EGFR (wt) (Cell-free assay) | EGFR (L858R/T790M) (Cell-free assay) | HER2 (Cell-free assay) | |
0.4 nM | 0.5 nM | 10 nM | 14 nM |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.58 mL | 102.9 mL | 205.8 mL |
0.5 mM | 4.12 mL | 20.58 mL | 41.16 mL |
1 mM | 2.06 mL | 10.29 mL | 20.58 mL |
5 mM | 0.41 mL | 2.06 mL | 4.12 mL |
*The above data is based on the productmolecular weight 485.9. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10141 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 485.9 |
Formula | C24H25ClFN5O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 439081-18-2 |
Synonyms | Tomtovok,Afatinib |
SMILES | CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4 |
产品标签
Product Questions
Product Questions
Canertinib (CI-1033)
Canertinib (CI-1033)是一种不可逆的酪氨酸激酶抑制剂,对EGFR(IC50 0.8 nM),HER-2(IC50 19 nM)和ErbB-4(IC50 7 nM)…
ARRY334543 (Varlitinib)
ARRY334543 (Varlitinib)是一种有效的EGFR和ErbB-2口服活性小分子抑制剂。
AG-18 (Tyrphostin 23)
AG-18 (Tyrphostin 23)是人表皮癌细胞系A431中的表皮生长因子(EGF)受体激酶抑制剂,IC50值为35M。
ARRY-543 (Varlitinib, ASLAN001)
ARRY-543 (Varlitinib,ASLAN001)是一种新型口服ErbB家族抑制剂,与批准的ErbB抑制剂不同,它直接或间接靶向ErbB家…
Pelitinib (EKB-569)
Pelitinib (EKB-569)是一种有效的,不可逆EGFR抑制剂,IC50为38.5 nM
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
ASP8273 (Naquotinib)
ASP8273 (Naquotinib)是不可逆的,第三代,选择性突变的表皮生长因子受体(EGFR)抑制剂,具有潜在的抗肿瘤…